Literature DB >> 12486323

Rituximab for immune hemolytic anemia following T- and B-Cell-depleted hematopoietic stem cell transplantation.

P Corti1, S Bonanomi, C Vallinoto, A Balduzzi, C Uderzo, G Cazzaniga, G Gaipa, M Dassi, P Perseghin, A Rovelli.   

Abstract

The treatment of immune-mediated hemolytic anemia (IHA) complicating hematopoietic stem cell transplantation (HSCT) is often unsatisfactory. We report a case of IHA which occurred after T- and B-cell depleted unrelated donor HSCT carried out for mucopolysaccharidosis type I-H (Hurler syndrome) which was successfully treated with anti-CD20+ monoclonal antibody Copyright 2003 S. Karger AG, Basel

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12486323     DOI： 10.1159/000067271

Source DB:  PubMed          Journal:  Acta Haematol        ISSN： 0001-5792            Impact factor:   2.195


  6 in total

Review 1.  The role of rituximab in autologous and allogeneic hematopoietic stem cell transplantation for non-Hodgkin's lymphoma.

Authors:  Elizabeth Naparstek
Journal:  Curr Hematol Malig Rep       Date:  2006-12       Impact factor: 3.952

Review 2.  Treatment with rituximab in benign and malignant hematologic disorders in children.

Authors:  Lisa B Giulino; James B Bussel; Ellis J Neufeld
Journal:  J Pediatr       Date:  2007-04       Impact factor: 4.406

Review 3.  Rituximab for passenger lymphocyte syndrome associated with allogeneic SCT.

Authors:  H J Lee; A Gulbis; L De Padua Silva; C Hosing; I Khouri; M de Lima; R E Champlin; S O Ciurea
Journal:  Bone Marrow Transplant       Date:  2008-03-17       Impact factor: 5.483

4.  Posttransplant autoimmune hemolytic anemia and other autoimmune cytopenias are increased in very young infants undergoing unrelated donor umbilical cord blood transplantation.

Authors:  Kristin M Page; Adam M Mendizabal; Vinod K Prasad; Paul L Martin; Suhag Parikh; Susan Wood; Gregory D Sempowski; Paul Szabolcs; Joanne Kurtzberg
Journal:  Biol Blood Marrow Transplant       Date:  2008-10       Impact factor: 5.742

5.  Treatment and response of autoimmune cytopenia occurring after allogeneic hematopoietic cell transplantation in children.

Authors:  Seok Hwang-Bo; Seong-Koo Kim; Jae Wook Lee; Pil-Sang Jang; Nack-Gyun Chung; Dae-Chul Jeong; Bin Cho; Hack-Ki Kim
Journal:  Blood Res       Date:  2017-06-22

6.  Autoimmune hematological diseases following haploidentical donor hematopoietic stem cell Transplant compared with matched sibling and unrelated donor.

Authors:  Weiran Lv; Zhiping Fan; Fen Huang; Na Xu; Li Xuan; Qianli Jiang; Hongsheng Zhou; Ren Lin; Xin Zhang; Jing Sun; Qifa Liu
Journal:  Oncotarget       Date:  2017-04-18
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.